Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Rotator Cuff Tear
NCT07456215Phase 1Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Dec 2022
- Primary completion
- Jan 2026
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, randomised trial of autologous platelet-rich plasma in rotator cuff tear (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoint: Movin score. Started Dec 2022; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT07456215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456215.